{"@id":"https://bioecon.ru/technology/autologous-muscle-precursor-cell-therapy/","@type":"Technology","cluster":"regenerative-personalized","formats":{"html":"https://bioecon.ru/technology/autologous-muscle-precursor-cell-therapy/","json":"https://bioecon.ru/api/v1/technology/autologous-muscle-precursor-cell-therapy/index.json"},"id":"autologous-muscle-precursor-cell-therapy","industries":["pharma","biomanufacturing"],"lang":"ru","links":{"industries":["https://bioecon.ru/industries/pharma/","https://bioecon.ru/industries/biomanufacturing/"],"suppliers":["https://bioecon.ru/companies/novartis/","https://bioecon.ru/companies/lonza-group/","https://bioecon.ru/companies/cryoport-systems/","https://bioecon.ru/companies/agc-biologics/","https://bioecon.ru/companies/astrazeneca/","https://bioecon.ru/companies/abinopharm/","https://bioecon.ru/companies/kheiron-biotech/","https://bioecon.ru/companies/pbs-biotech/","https://bioecon.ru/companies/impacfat/","https://bioecon.ru/companies/integriculture/","https://bioecon.ru/companies/simple-planet/","https://bioecon.ru/companies/cellmeat/"]},"maturity":7,"name":"Аутологичная клеточная терапия предшественниками миоцитов","regions":["ch","eu","us","cn"],"risk":"medium","section":"technology","sector":"health-biomedicine","sources":[{"date":"2026-11-22","entity":"Swiss Biotech Directory 2026","kind":"vendor","urls":["https://www.swissbiotech.org/directory/"]}],"stages":[{"n":1,"title":"Микробиопсия мышц бедра"},{"n":2,"title":"Селекция миобластов CD56+"},{"n":3,"title":"Наращивание в бессывороточных средах"},{"n":4,"title":"Инъекция в сфинктер под контролем УЗИ"}],"summary":"Выделение, наращивание по стандартам GMP и прицельное введение аутологичных CD56+ клеток-предшественниц миоцитов для регенерации сфинктера при недержании мочи.","url":"/technology/autologous-muscle-precursor-cell-therapy/","verified":"2026-11-22"}